| 書目名稱 | Oral Antidiabetics | | 編輯 | Jochen Kuhlmann,Walter Puls | | 視頻video | http://file.papertrans.cn/704/703513/703513.mp4 | | 叢書名稱 | Handbook of Experimental Pharmacology | | 圖書封面 |  | | 描述 | The prevalence of diabetes continues to increase worldwide. Traditionally, diabetes in its adult form has not been considered a serious life-threatening disease. This attitude needs to be changed because the complications asso- ciated with the adult form of diabetes affect almost every organ system. The high morbidity and mortality of non-insulin-dependent diabetes mellitus (NIDDM) suggest that current treatment strategies are unsatisfactory. We therefore face an urgent need for new therapeutic approaches. When the first Handbook 0/ Oral Antidiabetics was edited by H. Maske in 1971, the risks and benefits associated with the use of oral antidiabetics were still under discussion. Nowadays, oral antidiabetics hold a strong posi- tion in the long-term treatment of diabetes. Roughly 30% -50% of the patients with diabetes in Europe and the United States are treated with oral antidiabetics, chiefly sulfonylureas. While acknowledging the value of the ?- cytotropic sulfonylureas, we also need to recognize important limitations of their use, e.g., in the treatment of obese diabetic patients. | | 出版日期 | Book 1996 | | 關鍵詞 | Antidiabetics; Biguanides; Diabetes; Diabetes mellitus; Glucosidase inhibitors; Insulin; Non-Pharmacologic | | 版次 | 1 | | doi | https://doi.org/10.1007/978-3-662-09127-2 | | isbn_ebook | 978-3-662-09127-2Series ISSN 0171-2004 Series E-ISSN 1865-0325 | | issn_series | 0171-2004 | | copyright | Springer-Verlag Berlin Heidelberg 1996 |
The information of publication is updating
|
|
|Archiver|手機版|小黑屋|
派博傳思國際
( 京公網(wǎng)安備110108008328)
GMT+8, 2025-10-10 21:31
發(fā)表于 2025-3-21 16:19:58
